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Psychosocial Correlates of Gender-Based Violence
Among HIV-Infected and HIV-Uninfected Women
in Three US Cities
Rebecca M. Schwartz, PhD,1 Kathleen M. Weber, BSN,2 Gabrielle E. Schechter, BS,3 Nina C. Connors, BA,3
Yolene Gousse, MPH,4 Mary A. Young, MD,5 and Mardge H. Cohen, MD2,6
Abstract
Gender-based violence (GBV) is common among women with and at risk for HIV, yet little is known about the
GBV associated psychological factors that could be modifiable through behavioral interventions. The current
study examined the associations between some of these psychological factors (i.e., hopelessness, consideration
of future consequences, self esteem), mental health symptoms, substance abuse, and GBV among a sample of
736 HIV-infected and sociodemographically similar uninfected participants in the Women’s Interagency HIV
Study (WIHS). Results indicated high rates of lifetime GBV among the sample (58%), as well as high rates of
childhood sexual abuse (CSA) (22.2%). HIV-infected women were more likely to be hopeless and to experience
lower consideration of future consequences as compared to uninfected women. Multivariable analysis indicated
that current non-injection drug use and a history of injection drug use were the main correlates of GBV and
CSA, even when other psychosocial variables were included in analytic models. Being born outside of the US
reduced the likelihood of GBV and CSA. Future research directions and intervention implications are discussed.
Introduction
Women with histories of gender-based violence(GBV; a woman’s experience of childhood or adult
physical, sexual, or psychological abuse) are at significantly
greater risk for acquiring HIV.1–4 Women with such histo-
ries may lack self-efficacy over sexual practices and experi-
ence difficulty in negotiating condom use with high-risk
partners, placing them at higher risk for acquiring HIV.5,6
Additionally, prevalence studies estimate that 50–75% of
women who are already HIV-infected have experienced
GBV in their lifetime, and this is especially true for ethnic
minority women.2,4,7–9 It is important to examine how GBV
impacts both HIV-infected and uninfected women to better
understand the pathways that lead to risk behavior (e.g., risky
sex, substance use) among both groups, as well as the path-
ways that lead to HIV transmission risk among HIV-infected
women due to poor adherence to antiretroviral therapies and
poor engagement in care.10–13
A significant correlation between history of GBV and
increased use and abuse of psychoactive substances is
well documented among both HIV-infected and at-risk
women.1,3,14,15 Adult and childhood violence increases the
likelihood that women will experience problem drinking, and
an earlier onset as well as eventual diagnosis of alcohol
abuse.16–18 GBV is also associated with higher rates of co-
caine and injection drug use.1,19–21 These substances are
hypothesized to be used as coping strategies and/or a form of
self medication used to manage the emotional consequences
of abuse.6,22 Gender-based violence, HIV, and substance use
are co-occurring epidemics among low-income urban wo-
men, which impose an excess burden of disease on vulnerable
populations.23,24
Symptoms of mental health difficulties also play a role in
the influence that GBV has on HIV. PTSD and depression are
common among women with GBV histories.25–30 Women
who have experienced GBV are four to seven times more
likely to report experiencing minor and severe depressive
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symptoms compared to nonabused women.23,31 Compared to
uninfected women, some studies have found higher depres-
sion rates among women living with HIV.32 Furthermore,
meta-analyses have estimated PTSD prevalence rates ranging
between 31–84% among women with histories of GBV,
significantly higher than women in the general population.25
Evidence suggests that mental health disorders increase both
risk for substance abuse and inconsistent condom use.1,33,34
Studies have found that women with GBV-related PTSD and
depression have four times greater odds of having unpro-
tected sex with a risky partner (i.e., HIV-infected, injection
drug user and/or non-monogamous).25,34
Among HIV-infected and at-risk women, rates of child-
hood (i.e., prior to age 18) sexual abuse in particular (CSA; a
form of GBV when perpetrated against girls) are extremely
high, ranging from 32 to 76%.35–38 Studies indicate that CSA
is the type of trauma most associated with PTSD symptoms
among women.39–42 Additionally, the impact of CSA on
mental health and functioning is associated with increased
likelihood of engaging in both HIV acquisition and trans-
mission risk behavior including substance abuse (particu-
larly, injection drug use) and risky sex.15,38,43–45 One study
found that CSA was associated with an over 7-fold increase
in HIV risk behaviors among women.15 Furthermore, it is
important to include CSA in definitions of GBV, as well as
independently, as it is an important indicator for engagement
in care and confers increased risk for poor antiretroviral ad-
herence among HIV-infected women.43,44
Despite this knowledge, HIV risk reduction interventions
using traditional models of behavioral intervention have not
been very effective for women at-risk for HIV with GBV
histories, as well as among HIV-infected women with GBV
histories.4,46 Researchers have recognized the need to employ
more comprehensive, context driven, syndemic models to
examine and then modify the complex web of associations
between poverty, GBV, substance use, mental health symp-
tom burden, and sexual risk behavior.23,24 Intervention de-
sign incorporating these simultaneous epidemics should
address potentially modifiable psychological risk factors that
are cognitive and behavioral in nature, that are directly and
indirectly associated with GBV including feelings of hope-
lessness, the ability to consider future consequences, self-
esteem, and self-efficacy, among others.8,19
This study aims to identify possible psychological vari-
ables to target for HIV risk reduction interventions and im-
proved psychosocial well-being among both HIV-infected
and uninfected women with GBV histories including child-
hood sexual abuse.
Methods
Participants and procedure
Data for the current study were generated from a Gender-
Based Violence (GBV) substudy of the Women’s Interagency
HIV Study (WIHS). The WIHS, a longitudinal multicenter
cohort study of HIV-infected and demographically compa-
rable HIV-uninfected women, enrolled 2060 active partici-
pants enrolled either during 1994–1995 or 2001–2002 in six
cities across the United States. Women attend WIHS core
study visits every 6 months and they complete an inter-
viewer-assisted questionnaire in English or Spanish, in ad-
dition to a clinical exam and provision of biological
specimens. The methodology, training, quality assurance
activities, and cohort characteristics of the WIHS have been
published elsewhere.47,48
A total of 736 WIHS participants from three sites (i.e.,
Brooklyn, Chicago, and Washington, DC) who provided
written informed consent were enrolled in the GBV substudy
from October 1, 2009 to September 30, 2010. The majority of
participants completed the substudy questionnaires following
their WIHS core visit.
Measures
The current study included supplemental measures com-
pleted for the GBV substudy, specifically, and select mea-
sures from the corresponding WIHS core study visit.
Measures administered as part of the GBV substudy have
been widely used with similar populations and retain strong
psychometric properties as described below. They include an
indicator of GBV history, and measures of PTSD symptoms,
consideration of future consequences, hopelessness, and self-
esteem. The WIHS core visit measures included all demo-
graphic information, depressive symptoms, substance use,
and childhood sexual abuse history.
Lifetime history of gender-based violence (GBV) was re-
assessed at the time of the GBV substudy visit via a self-
report question. Each participant was queried as to whether
she experienced any physical or sexual abuse occurring at
any point in her lifetime. Psychological/emotional abuse
alone was not re-assessed as a distinct primary exposure of
interest for this study and therefore not included in our def-
inition of GBV. We categorized a participant as having a
lifetime GBV history if she answered ‘‘yes’’ to that question.
Childhood (prior to age 18) sexual abuse was included both
as part of the definition of GBV and separately in the analytic
models, as it is considered an independent predictor of mental
health difficulties above and beyond other types of GBV.46,49
We used the historical core WIHS visit data to categorize
CSA. Each participant was asked at a previous WIHS visit as
to whether she had experienced sexual coercion (including
any forced/unwanted sexual act) at any point in her lifetime.
If a participant responded ‘‘yes’’ then the age/s of sexual
coercion was asked. For the purposes of the current study, any
‘‘yes’’ responses that were associated with an age less than 18
was coded as affirmative for having experienced childhood
sexual abuse.
Depressive symptoms and substance use were assessed
during the WIHS core interview. All other independent
variables were assessed as part of the GBV substudy. All
variables were dichotomized. Depression symptoms were
measured using the Center for Epidemiologic Studies-
Depression Scale.50 Sum scores above 16/60 were considered
indicative of depressive symptoms (Cronbach’s alpha =
0.91). Substance use variables included current non-injection
drug use (NIDU; (any non-injection drug use over the past 6
months, excluding tobacco), current moderate/heavy alcohol
use ( ‡ three drinks per week51), and any history of injection
drug use (IDU). Self-esteem was assessed using the Rosen-
berg Self-Esteem Scale52 with sum scores less than 15/30
indicative of low self-esteem (Cronbach’s alpha = 0.87).
Hopelessness was assessed using the Beck Hopelessness
Scale53 with sum scores greater than 3/20 indicative of
greater hopelessness (Cronbach’s alpha = 0.86). The
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Consideration of Future Consequences Scale54 was used to
assess the degree to which a person considered the future
when making decisions about current behavior. Amean score
of less than 3/5 was indicative of lower consideration of fu-
ture consequences54 (Cronbach’s alpha = 0.67).
PTSD symptoms were assessed among the subset of sub-
study participants who reported a history of GBV. Women
cited the abuse experience that they considered ‘‘most
stressful’’ and answered questions regarding PTSD symp-
toms specific to that abuse experience. PTSD symptoms were
measured using the PTSD Checklist-Specific (PCL-S).55
Participants with sum scores above 44 (range is 17–85) were
considered as ‘‘probable PTSD’’56 (Cronbach’s alpha= 0.93).
Participants’ demographic data was collected as part of the
current or baseline WIHS core interview. Demographic
variables included in the current study were: HIV status, self-
reported age at time of substudy data collection (younger than
age 45, or 45 and older), education (high school graduate or
not), current employment status, annual household income
($18,000 per year or less), US-born, race/ethnicity (African
American, Hispanic, White, other), and marital status
(married/living with partner or not).
Data analysis
Bivariate associations were examined using Pearson Chi-
square analyses including differences in psychosocial vari-
ables by HIV status and differences in psychosocial variables
by GBV history and by CSA history. Multivariate associa-
tions between demographic, psychosocial, and GBV vari-
ables were examined using logistic regression. Significance
was determined using p values of < 0.05 and 95% confidence
intervals. SPSS version 21 (IBM) was used for data analysis.
Results
Demographic data indicated that almost three quarters of
the sample identified as African American, 13% Hispanic,
10%White, and 3% other. Twenty-one percent were not born
in the US. The sample also represented a low socioeconomic
status (SES) group as 57% were unemployed, 53% earned
less than $18,000 annually, and 33% had not finished high
school. Sixty-nine percent were not married nor living with a
partner. The mean age at the substudy visit was 45.17
(SD = 9.29). Seventy-three percent were HIV-infected and
27% were uninfected.
Overall, 58% of participants (total n = 735, one participant
did not answer) reported experiencing any lifetime GBV
(physical or sexual abuse only) in their lifetime and 22.2%
(total n= 698, 39 people did not answer) reported a history of
CSA.Mental health burden was relatively high with 30.1% of
the sample reporting probable depression, 4.4% reporting
low self-esteem, 20.9% reporting high levels of hopelessness,
and 19.4% reporting low consideration of future conse-
quences. In terms of substance use, 16.5% reported current
NIDU and 12.3% reported current problem drinking. Rates of
current injection drug use were too low to examine, however,
13.6% reported a lifetime history of IDU. Among those with
a lifetime GBV history, 15.3% reported probable PTSD.
When lifetime GBV, mental health, psychosocial and de-
mographic variables were examined by HIV status, there
were a number of significant differences (Table 1). Chi-
square analyses indicated that HIV-infected women were
significantly more likely to have a lessened ability to consider
future consequences when making decisions, were more likely
to be hopeless, were older, and were more likely to be unem-
ployed and lower income. Conversely, HIV-uninfected wo-
menweremore likely to engage inmoderate to heavy drinking,
were more likely to engage in current non-injection drug use,
were more likely to be married or living with a partner, and
were more likely to have been born outside the US.
Given the nonsignificant differences between HIV-
infected and uninfected women on lifetime GBV and CSA in
the current study, we examined differences between those
who experienced lifetime GBV and CSA and those who did
not, without stratifying by HIV status. Chi-square analyses
indicated significant differences between individuals who
experienced lifetime GBV and those that did not on both
psychosocial and demographic variables (Table 2). Women
who experienced GBV had higher rates of probable depres-
sion (Chi Square = 10.30), higher rates of current NIDU (Chi
Square = 25.62), and were more likely to have a history of
IDU (Chi Square= 19.95). Results of multivariate logistic
regression indicated that current NIDU was associated with
over a 2.6 times increased likelihood of having experienced
lifetime GBV, and having a history of IDU was also associ-
ated with over a 2.6 times increased likelihood of having
experienced lifetime GBV. In addition, being born outside
Table 1. Descriptive Information by HIV Status
HIV-uninfected
(n= 202)
HIV-infected
(n= 534) p Value
Ever experienced
GBV
55.9% 58.8% 0.478
Ever experienced
CSA
19.0% 23.3% 0.220
Probable depression 27.2% 31.0% 0.324
PTSD symptoms
(n = 421a)
12.7% 16.4% 0.360
Low consideration
of future
consequences*
13.9% 21.7% 0.018
High hopelessness* 12.6% 24.1% 0.001
Low self esteem 4.0% 4.5% 0.750
Problem drinking* 17.8% 10.5% 0.007
Non-injection
drug use*
21.8% 14.6% 0.019
History of injection
drug use
10.4% 15.1% 0.109
Married/living with
partner*
38.7% 27.8% 0.006
Age 45 and older* 42.1% 51.3% 0.025
Did not graduate
high school
29.9% 34.1% 0.270
Unemployed* 45.5% 61.6% 0.000
Low income* 44.9% 56.0% 0.010
Born outside US* 26.2% 18.5% 0.021
Race:
White 5.9% 11.4% 0.100
African
American
76.7% 73.4%
Hispanic 12.9% 12.5%
Other 4.5% 2.6%
*p < 0.05; aOnly those with GBV histories completed PTSD
symptom measure.
262 SCHWARTZ ET AL.
the US reduced the odds of experiencing lifetime GBV by
half (Table 3).
Similar patterns were found in those who experienced
childhood sexual abuse, specifically, in that participants who
experienced CSA had higher rates of probable depression
(Chi Square = 5.81), higher rates of hopelessness (Chi
Square = 5.49), higher rates of current NIDU (Chi Square =
13.28), and were more likely to have a history of IDU (Chi
Square = 27.78), in addition to a number of demographic
factors (Table 4). Multivariate logistic regression indicated
that, similar to overall lifetime GBV, current NIDU was as-
sociated with over a 2.1 times greater likelihood of having
experienced CSA, and having a history of IDU was associ-
ated with over a 2.5 times increased likelihood of having
experienced CSA. In addition, being born in the US, and
White race increased the odds of having a history of child-
hood sexual abuse (Table 5).
Given the increased rates of low consideration of future
consequences and hopelessness among HIV-infected women
as compared to the uninfected women and the significant
impact of lifetime GBV and CSA on NIDU among all par-
ticipants, we conducted post hoc analyses to determine
whether there was any interaction between lifetime GBV and
the aforementioned psychosocial variables on NIDU, as well
as any interaction between CSA and the psychosocial vari-
ables on NIDU among the HIV-infected women in the study.
Unadjusted analyses indicated a significant interaction be-
tween lifetime GBV and hopelessness on NIDU (OR = 2.45,
95% CI= 1.37, 4.38) and a significant interaction between
CSA and hopelessness on NIDU (OR = 2.35, 95% CI= 1.04,
5.31) among the HIV-infected participants. Specifically,
NIDU was most common among those HIV-infected partic-
ipants with a lifetime GBV history and high hopelessness
(26.3% engaged in NIDU) as compared to those with no
Table 2. Psychosocial and Demographic
Associations with Gender-Based Violence History
No GBV
history
(n = 308)
GBV
history
(n= 427) p Value
Probable depression* 23.4% 34.6% 0.001
Low consideration
of future consequences
21.5% 17.9% 0.275
High hopelessness 19.5% 21.8% 0.456
Low self esteem 2.9% 5.5% 0.104
Problem drinking 10.4% 13.7% 0.136
Non-injection drug use* 8.4% 22.5% 0.000
History of injection drug use* 6.8% 18.3% 0.000
Married/living with partner 30.9% 30.9% 0.969
Age 45 and older* 42.9% 52.5% 0.008
Did not graduate high school 35.4% 31.1% 0.226
Unemployed* 51.3% 61.5% 0.006
Low income* 47.1% 56.8% 0.012
Born outside US* 29.9% 14.2% 0.000
Race
White 8.1% 11.3% 0.382
African American 76.0% 73.3%
Hispanic 12.0% 12.8%
Other 3.9% 2.6%
HIV-infected 71.1% 73.3% 0.515
*p < 0.05
Table 3. Logistic Regression Model of Correlates
of Gender-Based Violence History
Odds
ratio
95%
Confidence
interval p Value
Probable depression 1.39 0.96–2.01 0.083
Non-injection drug use* 2.65 1.61–4.34 0.000
History of injection drug use* 2.58 1.46–4.54 0.001
Age 45 and older 1.07 0.76–1.52 0.685
Unemployed 1.06 0.73–1.54 0.770
Low Income 1.15 0.79–1.66 0.476
Born outside US* 0.52 0.35–0.78 0.002
*p < 0.05
Table 4. Psychosocial and Demographic
Associations with Childhood Sexual Abuse History
No CSA
history
(n = 544)
CSA
history
(n = 154) p Value
Probable depression* 27.4% 37.3% 0.016
Low consideration
of future consequences
18.1% 24.2% 0.110
High hopelessness* 18.9% 27.8% 0.019
Low self esteem 4.1% 6.5% 0.198
Problem drinking 11.1% 15.6% 0.163
Non-injection drug use* 14.0% 26.6% 0.000
History of injection drug use* 9.4% 26.5% 0.000
Married/living with partner 32.0% 28.9% 0.500
Age 45 and older* 44.5% 64.3% 0.000
Did not graduate high school 33.0% 28.8% 0.325
Unemployed 56.7% 55.8% 0.832
Low income 52.4% 53.4% 0.843
Born outside US* 24.6% 7.1% 0.000
Race*
White 7.0% 21.4% 0.000
African American 77.3% 67.6%
Hispanic 12.4% 8.4%
Other 3.3% 2.6%
HIV-infected 70.8% 76.0% 0.207
*p < 0.05
Table 5. Logistic Regression Model of Correlates
of Childhood Sexual Abuse History
Odds
ratio
95%
Confidence
interval
p
Value
Probable depression 1.03 0.66–1.63 0.888
High hopelessness 1.44 0.88–2.36 0.148
Non-injection drug use* 2.12 1.32–3.42 0.002
History of injection drug use* 2.59 1.52–4.40 0.000
Age 45 and older 1.52 0.99–2.33 0.058
Born outside US* 0.38 0.19–0.76 0.006
Race*
White
African American 0.31 0.18–0.53 0.000
Hispanic 0.27 0.12–0.60 0.001
Other 0.31 0.08–1.24 0.099
*p < 0.05.
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lifetime GBV history and low hopelessness (8.0% engaged in
NIDU). Similarly, NIDU was most common among HIV-
infected participants with a CSA history and high hopeless-
ness (28.1% engaged in NIDU) as compared to those with no
CSA history and low hopelessness (11.9% engaged in
NIDU). However, in adjusted analyses, being unemployed
was the strongest variable associated with current engage-
ment in NIDU (OR = 2.24, 95% CI = 1.13, 4.41) and the in-
teractions became non-significant.
Discussion
The findings of the current study underscore that substance
use is a recognized, but essential and undertreated correlate of
lifetime GBV. Current non-injection drug use and a history of
injection drug use were most strongly associated with life-
time GBV above and beyond the other psychosocial variables
of interest in the current study. Although the current study
sought to understand modifiable psychosocial correlates of
lifetime GBV such as self-esteem, hopelessness, and con-
sideration of future consequences, in addition to mental
health difficulties, these findings suggest that the modifiable
factor of non-injection drug use may be the most salient
factor to target in interventions. This is especially important
given the strong associations between substance use and
sexual risk, as well as between substance use and antiretroviral
adherence among HIV-infected women.20,27,43,44,49 Pre-
liminary research of the efficacy of trauma focused interven-
tions among substance abusing women indicate that these
interventions reduce PTSD symptoms and have a modest
impact on substance use.57 Future research is imperative in
order to understand the most effective treatment approaches
for low income, ethnic minority women with histories of GBV
and substance use. It is possible that engagement in substance
abuse treatment alone would mitigate PTSD symptoms, but it
is more likely that researchers need to consider syndemic
models of interventions that are culturally relevant for the
population.
Contrary to prior studies, there were no statistically sig-
nificant differences by HIV status in terms of rates of lifetime
GBV, CSA, depression or PTSD symptoms. However, there
were significant differences on psychosocial variables such
that HIV-infected women were more likely to have low
consideration of future consequences and higher levels of
hopelessness. Further analysis indicated that hopelessness
was particularly important among the HIV-infected women
and, in the unadjusted model, the interaction between hope-
lessness and both lifetime GBV and CSA conferred a sig-
nificant impact on engagement in current NIDU. Although
this interaction was not significant when employment was
considered, it again points to the fact that there are aspects of
mental health specific to women with HIV infection that need
to be considered in syndemic approaches to trauma and
substance use intervention. We may need to consider focus-
ing on reducing hopelessness in behavioral interventions that
involve HIV-infected women as it is a modifiable variable
that can be effectively targeted in cognitive behavioral in-
terventions and, in particular, new therapy techniques that
focus on future orientation.58,59 Further, the fact that the HIV-
infected women had a diminished ability to consider future
consequences as compared to their HIV-uninfected coun-
terparts indicates that this modifiable factor may also be
important to include in behavioral interventions targeted to-
ward HIV-infected women. Community-level interventions
based on empowerment models have been successful in re-
ducing GBV incidence among at-risk women and in de-
creasing HIV risk behaviors.60,61 Perhaps these models can
be applied to HIV-infected women grappling with substance
use issues as well, particularly if community empowerment
impacts individual-level hopelessness and consideration of
future consequences. Further, targeting economic empow-
erment as indicated by the strong effect of unemployment on
non-injection drug use among the HIV-infected women in the
study is also likely an important construct to target at the
macro-level.
The HIV-infected women did have higher rates of lifetime
GBV and CSA in the current study although the differences
were not statistically significant. The lack of significance may
be due to sample size issues or it could indicate that the two
groups are particularly well matched demographically and
that perhaps demographic factors placed all the women at
equally higher risk for GBV/CSA histories as compared to
their HIV status. Prospective research designs following
young women at risk for GBV would be useful in clarifying
some of the pathways that place both HIV-infected and un-
infected women at risk for violence exposure. Further, given
the clear risk for GBV among low SES women across HIV
status, it is possible that family-based intervention during
youth and adolescence among uninfected/at-risk individuals
and families may be most beneficial. Future intervention
development among HIV-uninfected women with GBV his-
tories may benefit from initially focusing on the impact of
GBV on substance use to determine whether substance use
treatment is enough to reduce trauma symptoms given the
strong association between GBV and substance use among
the uninfected women in this sample.
There were unexpected demographic findings in the cur-
rent research that warrant discussion. Results indicated that
being born outside of the US was possibly protective in terms
of GBV and CSA given the lower rates among non-US born
participants (GBV: 62.9% of the US born participants vs.
39.5% of the non-US born; CSA: 25.8% of the US born
participants vs. 7.6% of the non-US born participants). Lit-
erature typically points to immigrant women being at par-
ticularly high risk for victimization, particularly intimate
partner violence, due to many factors including the stress of
immigration, the experience of discrimination and margin-
alization in the US, loss of social networks, and increased
financial stress.62–66 Also, there is often under-reporting of
IPV, in particular, among immigrant women, largely having
to do with structural barriers, cultural barriers, and fears of
the US justice system, including possible fears of deporta-
tion.67–69 Given this information, it is possible that we were
seeing an under-reporting of abuse among our non-US born
participants. However, it is also possible that among the
current study participants, there is something protective
about being born outside of the US, perhaps having to do with
social networks and support that do exist among the immi-
grant women in our study. This possibility is augmented by
the fact that, in the current study, White race was a risk factor
for history of childhood sexual abuse andWhite race was also
highly correlated with non-immigrant status. Further, the
majority (62%) of women who identified as non-US born also
identified as being from the West Indies. More research with
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West Indian immigrants is needed, but initial studies indicate
that the pathways between GBV and mental health issues
differ between African Americans and those of West Indian
decent (both immigrants and non-immigrants).70
The study has a number of limitations. First, we used a
general definition of lifetime GBV and CSA that did not take
into account psychological abuse, threats of abuse, severity of
abuse, duration of abuse, or perpetrator. Previous research
has indicated differences in outcomes due to such factors, so
it is possible that results may have varied should we have
incorporated an ordinal scale of abuse.38,43,44 Further, the
GBV variable and CSA variable overlapped in that CSA was
part of the definition of GBV, thereby preventing us from
analyzing the relative contribution of physical violence,
physical violence during childhood, or violence only in
adulthood. Second, our psychosocial variables were collected
at one time point and it is possible that a longitudinal review
of psychosocial variables would indicate fluctuations that
were congruous with current abuse. Our rates of current GBV
(not lifetime) were too small to examine in data analysis.
Similarly, due to the cross-sectional nature of the psychoso-
cial variables, we were unable to determine causality, par-
ticularly in terms of the associations between HIV status
and hopelessness and between HIV status and consideration
of future consequences. Third, we relied on self-report data
regarding violence experience, mental health, and substance
use. As mentioned earlier, this may have resulted in under-
reporting, particularly amongmore marginalized groups such
as immigrant women, but most of the women in the current
study have been in the WIHS for at least 10 years and, as
such, are generally comfortable responding to questions of a
sensitive nature. Finally, theWIHS participants in the current
study have been in the WIHS cohort for either 10 or 15 years.
As such, they have been more exposed to routine follow-up
exams and data collection as compared to women living with
HIV in the general population. Therefore, results of the
current study may not be generalizable to the population of
women living with HIV or at risk for HIV in the US.
Future research should examine the impact of substance
use treatment on PTSD symptoms among women with GBV
and/or CSA histories, as well as to expand trauma focused
mental health services to women with substance use issues.
Preliminary intervention trials have had moderate success in
PTSD symptom reduction among HIV-uninfected women in
substance use treatment.57 Further, the current study under-
scores that, among women with HIV infection, it may be
important to target factors such as hopelessness and decreased
ability to consider future consequences in interventions
whether they have to do with substance use reduction, sexual
risk reduction, or promoting adherence to HIV medical care.
Finally, multi-level interventions and interventions coordi-
nated across multiple settings such as clinics, homes, schools,
and communities are likely to have the greatest impact on the
syndemic, co-occurring nature of HIV, poverty, violence,
substance use, and mental health issues among women.
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